Steroid–nucleosides possible novel agents for cancer chemotherapy View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1977-06

AUTHORS

J. E. VAN LIER, G. KAN, D. AUTENRIETH, V. N. NIGAM

ABSTRACT

THE major classes of anti-cancer chemotherapeutic drugs include alkylating agents, anti-metabolites of nucleic acids, steroid hormones and antibiotics1. Because of the lack of specificity of anti-tumour agents, attempts have been made to increase their specificity and cell-penetrating properties by coupling them to steroid hormones2,3. In particular, steroidal alkylating agents exhibit carcinostatic properties if used in combination with other modes of therapy4. We have prepared a novel class of agents by coupling steroids with naturally occurring purines and pyrimidines by way of a C–N linkage. The structures are unique in that they may be regarded as analogues both of steroid hormones and of ‘nucleosides’ in which the sugar has been replaced. Accordingly, we may expect their steroid moiety to provide target specificity, while their nucleoside characteristics may result in interference at the DNA level to give the desired anti-tumour activity. Preliminary studies on the effect of steroid–nucleosides on the lifespan of tumour-bearing animals show that selectively coupled products exhibit anti-tumour activity. More... »

PAGES

522

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/267522a0

DOI

http://dx.doi.org/10.1038/267522a0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1023990002

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/876369


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mammary Neoplasms, Experimental", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nucleosides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats, Inbred F344", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Steroids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Structure-Activity Relationship", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "familyName": "VAN LIER", 
        "givenName": "J. E.", 
        "id": "sg:person.0707506374.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707506374.64"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "KAN", 
        "givenName": "G.", 
        "id": "sg:person.057222532.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.057222532.85"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "AUTENRIETH", 
        "givenName": "D.", 
        "id": "sg:person.0104657707.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0104657707.48"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "NIGAM", 
        "givenName": "V. N.", 
        "id": "sg:person.0110521007.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0110521007.56"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/0024-3205(74)90070-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008300775"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0024-3205(74)90070-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008300775"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/jm00281a016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055941131"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1080639342", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1977-06", 
    "datePublishedReg": "1977-06-01", 
    "description": "THE major classes of anti-cancer chemotherapeutic drugs include alkylating agents, anti-metabolites of nucleic acids, steroid hormones and antibiotics1. Because of the lack of specificity of anti-tumour agents, attempts have been made to increase their specificity and cell-penetrating properties by coupling them to steroid hormones2,3. In particular, steroidal alkylating agents exhibit carcinostatic properties if used in combination with other modes of therapy4. We have prepared a novel class of agents by coupling steroids with naturally occurring purines and pyrimidines by way of a C\u2013N linkage. The structures are unique in that they may be regarded as analogues both of steroid hormones and of \u2018nucleosides\u2019 in which the sugar has been replaced. Accordingly, we may expect their steroid moiety to provide target specificity, while their nucleoside characteristics may result in interference at the DNA level to give the desired anti-tumour activity. Preliminary studies on the effect of steroid\u2013nucleosides on the lifespan of tumour-bearing animals show that selectively coupled products exhibit anti-tumour activity.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/267522a0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1018957", 
        "issn": [
          "0090-0028", 
          "1476-4687"
        ], 
        "name": "Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5611", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "267"
      }
    ], 
    "name": "Steroid\u2013nucleosides possible novel agents for cancer chemotherapy", 
    "pagination": "522", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "724a9dcc5db7a63cf1f88abf14d50e6618ad0350d9460843aca12c24fbbcb52b"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "876369"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0410462"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/267522a0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1023990002"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/267522a0", 
      "https://app.dimensions.ai/details/publication/pub.1023990002"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T00:55", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8697_00000424.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/267522a0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/267522a0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/267522a0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/267522a0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/267522a0'


 

This table displays all metadata directly associated to this object as RDF triples.

123 TRIPLES      21 PREDICATES      40 URIs      29 LITERALS      17 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/267522a0 schema:about N3405c57d877c4690979d4e49c3ed35e3
2 N3e4bb02c0c814d9cb28c7bad5c1af955
3 N470fdf4bb419415b9f0486d30d32c061
4 N7cb44102d43f466184968b8876a1ede0
5 N9d145cb91d604035846bcd03f70fda21
6 Nd46789110fb445c18782349ccb49594f
7 Nd617c9ea12f44e2584eb251837f10f81
8 Nf8fcc7c76cfa4e37bf7e86d0a3f8fe72
9 anzsrc-for:11
10 anzsrc-for:1115
11 schema:author N9d7bf433ae0f496d8404f807f03c3ef8
12 schema:citation https://app.dimensions.ai/details/publication/pub.1080639342
13 https://doi.org/10.1016/0024-3205(74)90070-8
14 https://doi.org/10.1021/jm00281a016
15 schema:datePublished 1977-06
16 schema:datePublishedReg 1977-06-01
17 schema:description THE major classes of anti-cancer chemotherapeutic drugs include alkylating agents, anti-metabolites of nucleic acids, steroid hormones and antibiotics1. Because of the lack of specificity of anti-tumour agents, attempts have been made to increase their specificity and cell-penetrating properties by coupling them to steroid hormones2,3. In particular, steroidal alkylating agents exhibit carcinostatic properties if used in combination with other modes of therapy4. We have prepared a novel class of agents by coupling steroids with naturally occurring purines and pyrimidines by way of a C–N linkage. The structures are unique in that they may be regarded as analogues both of steroid hormones and of ‘nucleosides’ in which the sugar has been replaced. Accordingly, we may expect their steroid moiety to provide target specificity, while their nucleoside characteristics may result in interference at the DNA level to give the desired anti-tumour activity. Preliminary studies on the effect of steroid–nucleosides on the lifespan of tumour-bearing animals show that selectively coupled products exhibit anti-tumour activity.
18 schema:genre research_article
19 schema:inLanguage en
20 schema:isAccessibleForFree false
21 schema:isPartOf N7f56eed5d96146e691fd3b2403d02eb7
22 Nb29c30e9ef9f491795440a9d513bc5bf
23 sg:journal.1018957
24 schema:name Steroid–nucleosides possible novel agents for cancer chemotherapy
25 schema:pagination 522
26 schema:productId N0021130696e3425a85cf21a61256b08d
27 N31a9fdaa41fc446b9365ee5dd0c7e950
28 N3f592d9a1e454a6d93d01ff8aa7e5e12
29 N55cdb0c24cf84209b770f3359d3aecba
30 Ned16bf2195e040b88d950ed6a145ea2d
31 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023990002
32 https://doi.org/10.1038/267522a0
33 schema:sdDatePublished 2019-04-11T00:55
34 schema:sdLicense https://scigraph.springernature.com/explorer/license/
35 schema:sdPublisher N90ed0005c2af4748a57002ddb8fc3d96
36 schema:url https://www.nature.com/articles/267522a0
37 sgo:license sg:explorer/license/
38 sgo:sdDataset articles
39 rdf:type schema:ScholarlyArticle
40 N0021130696e3425a85cf21a61256b08d schema:name doi
41 schema:value 10.1038/267522a0
42 rdf:type schema:PropertyValue
43 N31a9fdaa41fc446b9365ee5dd0c7e950 schema:name readcube_id
44 schema:value 724a9dcc5db7a63cf1f88abf14d50e6618ad0350d9460843aca12c24fbbcb52b
45 rdf:type schema:PropertyValue
46 N3405c57d877c4690979d4e49c3ed35e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
47 schema:name Rats
48 rdf:type schema:DefinedTerm
49 N3e4bb02c0c814d9cb28c7bad5c1af955 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
50 schema:name Mammary Neoplasms, Experimental
51 rdf:type schema:DefinedTerm
52 N3f592d9a1e454a6d93d01ff8aa7e5e12 schema:name dimensions_id
53 schema:value pub.1023990002
54 rdf:type schema:PropertyValue
55 N470fdf4bb419415b9f0486d30d32c061 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
56 schema:name Structure-Activity Relationship
57 rdf:type schema:DefinedTerm
58 N55cdb0c24cf84209b770f3359d3aecba schema:name nlm_unique_id
59 schema:value 0410462
60 rdf:type schema:PropertyValue
61 N6f800f8cb88c4b06bf7a001bf4a3a2ea rdf:first sg:person.0110521007.56
62 rdf:rest rdf:nil
63 N7cb44102d43f466184968b8876a1ede0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
64 schema:name Rats, Inbred F344
65 rdf:type schema:DefinedTerm
66 N7f56eed5d96146e691fd3b2403d02eb7 schema:volumeNumber 267
67 rdf:type schema:PublicationVolume
68 N877d2d3a239645c78e90be52409596f2 rdf:first sg:person.0104657707.48
69 rdf:rest N6f800f8cb88c4b06bf7a001bf4a3a2ea
70 N90ed0005c2af4748a57002ddb8fc3d96 schema:name Springer Nature - SN SciGraph project
71 rdf:type schema:Organization
72 N9d145cb91d604035846bcd03f70fda21 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Steroids
74 rdf:type schema:DefinedTerm
75 N9d7bf433ae0f496d8404f807f03c3ef8 rdf:first sg:person.0707506374.64
76 rdf:rest Naf7a83b9681246d5a6d3126e691a74e7
77 Naf7a83b9681246d5a6d3126e691a74e7 rdf:first sg:person.057222532.85
78 rdf:rest N877d2d3a239645c78e90be52409596f2
79 Nb29c30e9ef9f491795440a9d513bc5bf schema:issueNumber 5611
80 rdf:type schema:PublicationIssue
81 Nd46789110fb445c18782349ccb49594f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Animals
83 rdf:type schema:DefinedTerm
84 Nd617c9ea12f44e2584eb251837f10f81 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Female
86 rdf:type schema:DefinedTerm
87 Ned16bf2195e040b88d950ed6a145ea2d schema:name pubmed_id
88 schema:value 876369
89 rdf:type schema:PropertyValue
90 Nf8fcc7c76cfa4e37bf7e86d0a3f8fe72 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Nucleosides
92 rdf:type schema:DefinedTerm
93 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
94 schema:name Medical and Health Sciences
95 rdf:type schema:DefinedTerm
96 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
97 schema:name Pharmacology and Pharmaceutical Sciences
98 rdf:type schema:DefinedTerm
99 sg:journal.1018957 schema:issn 0090-0028
100 1476-4687
101 schema:name Nature
102 rdf:type schema:Periodical
103 sg:person.0104657707.48 schema:familyName AUTENRIETH
104 schema:givenName D.
105 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0104657707.48
106 rdf:type schema:Person
107 sg:person.0110521007.56 schema:familyName NIGAM
108 schema:givenName V. N.
109 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0110521007.56
110 rdf:type schema:Person
111 sg:person.057222532.85 schema:familyName KAN
112 schema:givenName G.
113 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.057222532.85
114 rdf:type schema:Person
115 sg:person.0707506374.64 schema:familyName VAN LIER
116 schema:givenName J. E.
117 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707506374.64
118 rdf:type schema:Person
119 https://app.dimensions.ai/details/publication/pub.1080639342 schema:CreativeWork
120 https://doi.org/10.1016/0024-3205(74)90070-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008300775
121 rdf:type schema:CreativeWork
122 https://doi.org/10.1021/jm00281a016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1055941131
123 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...